magnesium carbonate has been researched along with Vascular Calcification in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adorni, MP; Biancorosso, N; Bressan, A; Brilli, E; Chen, H; Dall'Acqua, S; Faggin, E; Ferri, N; Lupo, MG; Neutel, C; Rattazzi, M; Salvalaio, M; Sut, S; Tarantino, G; Vivian, G | 1 |
| Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
| Goumenos, DS; Papachristou, E; Sonikian, M | 1 |
| Damianakis, NE; Giannakis, N; Oreopoulos, DG; Papadaki, AN; Stamataki, EE; Tzanakis, IP | 1 |
| Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
1 review(s) available for magnesium carbonate and Vascular Calcification
| Article | Year |
|---|---|
Optimal use of phosphate binders in chronic kidney disease.
Topics: Aluminum Hydroxide; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Lanthanum; Magnesium; Patient Compliance; Phosphates; Polyamines; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification | 2013 |
1 trial(s) available for magnesium carbonate and Vascular Calcification
| Article | Year |
|---|---|
Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Magnesium; Male; Peripheral Arterial Disease; Pilot Projects; Prospective Studies; Renal Dialysis; Treatment Outcome; Vascular Calcification | 2014 |
3 other study(ies) available for magnesium carbonate and Vascular Calcification
| Article | Year |
|---|---|
Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line.
Topics: Acyl Coenzyme A; Adenine; Animals; Anticholesteremic Agents; Cell Line, Tumor; Cholesterol; Cysteine; Dietary Supplements; Humans; Hypercholesterolemia; Iron; Magnesium; Male; Rats, Sprague-Dawley; Receptors, LDL; Renal Insufficiency, Chronic; Simvastatin; Uremia; Vascular Calcification | 2020 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |